{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:22:45Z","timestamp":1785414165695,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"DOI":"10.7759\/cureus.103544","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:15:51Z","timestamp":1771010151000},"source":"Crossref","is-referenced-by-count":1,"title":["Short-Interval Mifepristone-Misoprostol Versus Misoprostol Alone for Second-Trimester Abortion: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Ala","family":"Aiob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Gumin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneen","family":"Abu Shqara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshirah","family":"Sgayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishalom","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006714.pub2","article-title":"Surgical versus medical methods for second trimester induced abortion","author":"Lohr PA","year":"2008","unstructured":"Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev. 2008, CD006714. 10.1002\/14651858.CD006714.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.06.009","article-title":"Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study","volume":"102","author":"Henkel A","year":"2020","unstructured":"Henkel A, Lerma K, Blumenthal PD, Shaw KA. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study. Contraception. 2020, 102:327-31. 10.1016\/j.contraception.2020.06.009","journal-title":"Contraception"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005153","article-title":"Abortion access and medically complex pregnancies before and after Texas Senate Bill 8","volume":"141","author":"Arey W","year":"2023","unstructured":"Arey W, Lerma K, Carpenter E, et al.. Abortion access and medically complex pregnancies before and after Texas Senate Bill 8. Obstet Gynecol. 2023, 141:995-1003. 10.1097\/AOG.0000000000005153","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000409","article-title":"Update on second trimester medical abortion","volume":"29","author":"Lerma K","year":"2017","unstructured":"Lerma K, Shaw KA. Update on second trimester medical abortion. Curr Opin Obstet Gynecol. 2017, 29:413-8. 10.1097\/GCO.0000000000000409","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02712.x","article-title":"Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial","volume":"117","author":"Kelly T","year":"2010","unstructured":"Kelly T, Suddes J, Howel D, Hewison J, Robson S. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial. BJOG. 2010, 117:1512-20. 10.1111\/j.1471-0528.2010.02712.x","journal-title":"BJOG"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4346","article-title":"Induction of labor compared to dilation and evacuation for postmortem analysis","volume":"34","author":"Lal AK","year":"2014","unstructured":"Lal AK, Kominiarek MA, Sprawka NM. Induction of labor compared to dilation and evacuation for postmortem analysis. Prenat Diagn. 2014, 34:547-51. 10.1002\/pd.4346","journal-title":"Prenat Diagn"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000431056.79334.cc","article-title":"Practice bulletin no. 135: second-trimester abortion","volume":"121","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2013","unstructured":"Committee on Practice Bulletins\u2014Gynecology. Practice bulletin no. 135: second-trimester abortion. Obstet Gynecol. 2013, 121:1394-406. 10.1097\/01.AOG.0000431056.79334.cc","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182932f37","article-title":"Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review","volume":"121","author":"Shaw KA","year":"2013","unstructured":"Shaw KA, Topp NJ, Shaw JG, Blumenthal PD. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review. Obstet Gynecol. 2013, 121:1335-47. 10.1097\/AOG.0b013e3182932f37","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004344","article-title":"Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation: a randomized controlled trial","volume":"137","author":"Allanson ER","year":"2021","unstructured":"Allanson ER, Copson S, Spilsbury K, et al.. Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation: a randomized controlled trial. Obstet Gynecol. 2021, 137:801-9. 10.1097\/AOG.0000000000004344","journal-title":"Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.02.023","article-title":"A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy","volume":"130","author":"Dabash R","year":"2015","unstructured":"Dabash R, Chelli H, Hajri S, Shochet T, Raghavan S, Winikoff B. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy. Int J Gynaecol Obstet. 2015, 130:40-4. 10.1016\/j.ijgo.2015.02.023","journal-title":"Int J Gynaecol Obstet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51697","article-title":"Late termination of pregnancy at a major Queensland tertiary hospital, 2010-2020","volume":"217","author":"Rosser S","year":"2022","unstructured":"Rosser S, Sekar R, Laporte J, et al.. Late termination of pregnancy at a major Queensland tertiary hospital, 2010-2020. Med J Aust. 2022, 217:410-4. 10.5694\/mja2.51697","journal-title":"Med J Aust"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.12.010","article-title":"No. 360-induced abortion: surgical abortion and second trimester medical methods","volume":"40","author":"Costescu D","year":"2018","unstructured":"Costescu D, Guilbert \u00c9. No. 360-induced abortion: surgical abortion and second trimester medical methods. J Obstet Gynaecol Can. 2018, 40:750-83. 10.1016\/j.jogc.2017.12.010","journal-title":"J Obstet Gynaecol Can"},{"key":"ref13","article-title":"Best practice in abortion care","author":"Royal College of Obstetricians and Gynaecologists","year":"2022","unstructured":"Royal College of Obstetricians and Gynaecologists. Best practice in abortion care. RCOG. 2022,","journal-title":"RCOG"},{"key":"ref14","article-title":"Abortion care guideline","year":"2022","unstructured":"Abortion care guideline. World Health Organization, Geneva; 2022."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.110143","article-title":"Society of family planning clinical recommendation: medication abortion between 14 0\/7 and 27 6\/7 weeks of gestation: jointly developed with the Society for Maternal-Fetal Medicine","volume":"129","author":"Zwerling B","year":"2024","unstructured":"Zwerling B, Edelman A, Jackson A, Burke A, Prabhu M. Society of family planning clinical recommendation: medication abortion between 14 0\/7 and 27 6\/7 weeks of gestation: jointly developed with the Society for Maternal-Fetal Medicine. Contraception. 2024, 129:110143. 10.1016\/j.contraception.2023.110143","journal-title":"Contraception"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-011-0118-4","article-title":"Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy","volume":"61","author":"Nagaria T","year":"2011","unstructured":"Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy. J Obstet Gynaecol India. 2011, 61:659-62. 10.1007\/s13224-011-0118-4","journal-title":"J Obstet Gynaecol India"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.04.007","article-title":"Mifepristone and misoprostol for cervical ripening in surgical abortion between 12 and 14 weeks of gestation: a randomized controlled trial","volume":"201","author":"Ohannessian A","year":"2016","unstructured":"Ohannessian A, Baumstarck K, Maruani J, Cohen-Solal E, Auquier P, Agostini A. Mifepristone and misoprostol for cervical ripening in surgical abortion between 12 and 14 weeks of gestation: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016, 201:151-5. 10.1016\/j.ejogrb.2016.04.007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp N","year":"2007","unstructured":"Kapp N, Borgatta L, Stubblefield P, Vragovic O, Moreno N. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol. 2007, 110:1304-10. 10.1097\/01.AOG.0000289577.32274.a5","journal-title":"Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458112-short-interval-mifepristone-misoprostol-versus-misoprostol-alone-for-second-trimester-abortion-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:15:52Z","timestamp":1771010152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458112-short-interval-mifepristone-misoprostol-versus-misoprostol-alone-for-second-trimester-abortion-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.103544","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}